Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CD30 Ligand/TNFSF8 Antibody (116621) [PerCP], Novus Biologicals™
SDP

Catalog No. NB402069 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB402069 0.1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB402069 Supplier Novus Biologicals Supplier No. FAB10281C
Add to Cart
Add to Cart

Mouse Monoclonal Antibody

CD30 Ligand/TNFSF8 Monoclonal antibody specifically detects CD30 Ligand/TNFSF8 in Human samples. It is validated for Flow Cytometry, Immunohistochemistry, CyTOF

Specifications

Antigen CD30 Ligand/TNFSF8
Applications Flow Cytometry, Immunohistochemistry, CyTOF
Classification Monoclonal
Clone 116621
Conjugate PerCP
Dilution Flow Cytometry, Immunohistochemistry, CyTOF-ready
Formulation PBS
Gene Alias CD153, CD153 antigen, CD30 antigen ligand, CD30-L, CD30LCD30 ligand, CD30LGMGC138144, tumor necrosis factor (ligand) superfamily, member 8, tumor necrosis factor ligand superfamily member 8
Host Species Mouse
Immunogen Mouse myeloma cell line NS0-derived human CD30 Ligand/TNFSF8., Gln63-Asp234, Accession # P32971
Purification Method Protein A or G purified from hybridoma culture supernatant
Quantity 0.1 mL
Regulatory Status RUO
Research Discipline Apoptosis, Cancer
Primary or Secondary Primary
Gene ID (Entrez) 944
Target Species Human
Content And Storage Store at 4°C in the dark.
Form Purified
Isotype IgG2a
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.